Buron Nutrascience Corp (BRCNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,096 | -1,366 | -5,520 | -3,949 | -2,494 |
| Depreciation Amortization | 260 | 127 | 520 | 353 | 242 |
| Accounts receivable | 151 | 122 | -145 | 148 | 117 |
| Other Working Capital | 136 | -326 | -78 | 21 | 14 |
| Other Operating Activity | 323 | 95 | 942 | 435 | 186 |
| Operating Cash Flow | $-2,227 | $-1,348 | $-4,283 | $-2,991 | $-1,934 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -148 | -128 | -94 | -75 | -34 |
| Other Investing Activity | 32 | 21 | 65 | 52 | 42 |
| Investing Cash Flow | $-116 | $-106 | $-29 | $-23 | $8 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 741 | N/A | N/A |
| Common Stock Issued | 84 | N/A | 5,766 | 2,507 | 2,544 |
| Other Financing Activity | -62 | -48 | -158 | -49 | -43 |
| Financing Cash Flow | $22 | $-48 | $6,349 | $2,458 | $2,501 |
| Exchange Rate Effect | 5 | 16 | -6 | -17 | -1 |
| Beginning Cash Position | 3,077 | 3,067 | 1,080 | 1,070 | 1,086 |
| End Cash Position | 760 | 1,580 | 3,111 | 496 | 1,660 |
| Net Cash Flow | $-2,316 | $-1,487 | $2,031 | $-574 | $575 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,227 | -1,348 | -4,283 | -2,991 | -1,934 |
| Capital Expenditure | -148 | -128 | -94 | -75 | -34 |
| Free Cash Flow | -2,375 | -1,476 | -4,377 | -3,066 | -1,968 |